DIETARY FIBERS IN THE CORRECTION OF DYSLIPIDEMIA
Issue:
9
Year:
2016
The paper discusses whether dyslipidemia that contributes to the occurrence and progression of atherosclerosis may be corrected with psyllium-containing medications.
Keywords:
dyslipidemia
psyllium
atherosclerosis
statins
References:
- Ardatskaja M.D. Sovremennye problemy fiziologii i patologii pischevarenija // Ros. zhurn. gastroenterol., gepatol., koloproktol. (Pril. №14: Materialy XVI sessii Akademicheskoj shkoly-seminara imeni A.M. Ugoleva). – 2001; 11 (4): 91–102.
- Ginzburg M.M. Opyt primenenija preparata Mukofal'k v kompleksnoj terapii u patsientov s ozhireniem i metabolicheskim sindromom / Samara, 2010; s. 9.
- Golovanova E.V. Pischevye volok na v korrektsii dislipidemii u patsi-entov so steatozom pecheni // Vrach. – 2014; 12: 22–6.
- Diagnostika i korrektsija naru shenij lipidnogo obmena s tsel'ju pro-filaktiki i lechenija ateroskleroza. Rossijskie rekomendatsii V peresmotr / M., 2012; 29 s.
- Komisarenko I.A., Levchenko S.V. Korrektsija dislipidemii v praktike terapevta. Metod. rukovodstvo: dlja vrachej-terapevtov, gastroenterologov, kardiologov, slushatelej kursov povy-shenija kvalifikatsii, aspirantov i studentov st. kursov med. in-tov / M.: Prima Print, 2014; 64 s.
- Obschie rekomendatsii po leche niju dislipidemii. Memorandum Mezhdunarodnogo obschestva po izuche-niju ateroskleroza / M.: 2014; 96 s.
- Radchenko V.G., Seliverstov P.V., Sitkin S.I. i dr. Pischevye volokna v klinicheskoj praktike // Klin. perspek-tivy gastroenterol., gepatol. – 2010; 1: 21–8.
- Rol' pischevyh volokon pri metabolicheskom sindrome : usovershen. med. tehnologija: metod. rekomendatsii. Kom. po zdravoohraneniju pravitel'stva Sankt-Peterburga, M-vo zdravoohranenija i sots. razvitija Rossijskoj Federatsii, Sankt-Peterburgskaja gos. med. akad. im. I.I. Mechnikova; sost. V. G. Radchenko i dr. / M., 2011; 32 s.
- Rumjantsev V.G. Preparaty Plantago v reguljatsii dejatel'nosti pischevari-tel'nogo trakta // Klinicheskaja meditsina. – 1997; 75 (11): 19–23.
- Moreyra A., Alan C. et al. Effect of Combining Psyllium Fiber With Simvastatin in Lowering Cholesterol // Arch. Intern. Med. – 2005; 165: 1161–6.
- Anderson J. et al. Cholesterol-lowering effects of psyllium intake adjunctive 11. to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials // Am. J. Clin. Nutr. – 2000; 71 (2): 472–9.
- Anderson J. et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men // Arch. Intern. Med. – 1988; 148 (2): 292–6.
- Bays H., Stein E. Pharmacotherapy for dyslipedaemia – current therapies 13. and future agtnts // Exp. Opin. Pharmacother – 2003; 4: 1901–58.
- Brown L., Rosner B., Willett W. et al. Cholesterol-lowering effects of dietary 14. fiber: a meta-analysis // Am. J. Clin. Nutr. – 1999; 69: 30–42.
- Mihaylova B., Emberson J., Blackwell L. et al. The effects of lowering LDL 15. cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials // Lancet. – 2012; 380: 581–90.
- Baigent C., Blackwell L., Emberson J. et al. Efficacy and safety of more 16. intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials // Lancet. – 2010; 376: 1670–81.
- Gupta R., Argawal C., Singh G. et al. Lipid-lowering efficacy of psyllium 17. hydrophilic mucilloid in non insulin dependent diabetes mellitus with hypercholesterolemia // Indian J. Med. Res. – 1994; 100: 237–41.
- Jenkins D., Kendall C., Axelsen M. et al. Viscous and nonviscous fibres, 18. nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease // Curr. Opin. Lipidol. – 2000; 11: 49–56.
- Marlett J., Kajs T., Fischer M. An unfermented gel component of psyllium 19. seed husk promotes laxation as a lubricant in humans // Am. J. Clin. Nutr. – 2000; 72: 784–9.
- Jun M., Foote C., Lv J. et al. Effects of fibrates on cardiovascular outcomes: 20. a systematic review and meta-analysis // Lancet. – 2010; 375: 1875–84.
- Law M., Wald N., Rudnicka A. Quantifying effect of statins on low density 21. lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis // BMJ. – 2003; 326 (7404): 1423.
- Lee M., Saver J., Towfighi A. et al. Efficacy of fibrates for cardiovascular risk 22. reduction in persons with atherogenic dyslipidemia: a meta-analysis // Atherosclerosis. – 2011; 217: 492–8.
- Marlett J., Fischer M. The active fraction of psyllium seed husk // Proc. Nutr. 23. Soc. – 2003; 62: 207–9.
- Marlett J., Kajs T., Fischer M. An unfermented gel component of psyllium 24. seed husk promotes laxation as a lubricant in humans // Am. J. Clin. Nutr. – 2000; 72: 784–9.
- Ros E., Hu F. Consumption of plant seeds and cardiovascular health: 25. epidemiologic and clinical trial evidence // Circulation. – 2013; 128 (5); 553–65.
- Spence J., Huff M., Heidenheim P. et al. Combination therapy with 26. Colestipol and psyllium mucilloid in patients with hyperlipidemia // Ann. Intern. Med. – 1995; 123: 493–9.
- Van Rosendaal G., Shaffer E., Edwards A. et al. Effect of time of 27. administration on cholesterol-lowering by psyllium: a randomized cross-over study in normocholesterolemic or slightly hypercholesterolemic subjects // Nutr. J. – 2004; 28: 17.
- Wolever T., Jenkins D., Mueller S. et al. Method of administration influences 28. the serum cholesterol-lowering effect of psyllium // Am. J. Clin. Nutr. – 1994; 59: 1055–9.
- Ziai S., Larijani B., Akhoondzadeh S. et al. Psyllium decreased serum 29. glucose and glycosylated hemoglobin significantly in diabetic outpatients // J. Ethnopharmacol. – 2005; 102: 202–7.